Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Health Canada · 3 medicines
AEMPS · 3 medicines
MS · 3 medicines · Historical list
SFDA · 2 medicines · Historical list
Anvisa · 1 medicine
EMA · 1 medicine
AIFA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
24 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Orencia | United States | 250MG | injectable | Marketed | Bristol Myers Squibb |
| Orencia | United States | 125MG/ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Orencia | United States | 50MG/0.4ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Orencia | United States | 87.5MG/0.7ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Orencia | United States | 125MG/ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Orencia | European Union | Authorised | Bristol-Myers Squibb Pharma EEIG | ||
| ORENCIA 125 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA | Spain | 125,875 mg | solución inyectable en jeringa precargada | Marketed | Bristol-Myers Squibb Pharma Eeig |
| ORENCIA 125 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | Spain | 125,875 mg | solución inyectable en pluma precargada | Marketed | Bristol-Myers Squibb Pharma Eeig |
| ORENCIA 250 mg POLVO PARA CONCENTRADO PARA SOL. PARA PERFUSION | Spain | 250 mg | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Orencia | Italy | Soluzione iniettabile | Authorised | Bristol-Myers Squibb Pharma Eeig | |
| ORENCIA 125 mg oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| ORENCIA 250 mg poeder voor concentraat voor oplossing voor infusie. | Netherlands | Authorised | Bristol-Myers Squibb Pharma EEIG | ||
| ORENCIA 50 mg oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| ORENCIA 87,5 mg oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| Orencia | Canada | 250 MG / VIAL | Powder For Solution | Marketed | Bristol-Myers Squibb Canada |
| Orencia | Canada | 125 MG / ML | Solution | Marketed | Bristol-Myers Squibb Canada |
| Orencia | Brazil | Authorised | Bristol-Myers Squibb Farmacêutica Ltda | ||
| Orencia | Croatia | Authorised | |||
| ORENCIA 125MG Solution for injection in pre-filled syringe | Saudi Arabia | Authorised | BRISTOL-MYERS SQUIBB HOLDINGS PHARMA, Ltd. LIABBILITY COMPANY | ||
| Orencia 250MG Powder for Solution for Infusion | Saudi Arabia | Authorised | Bristol-Myers Squibb | ||
| Orencia | Canada | 125 MG / ML | Solution | Cancelled | Bristol-Myers Squibb Canada |
| ORENCIA 125 mg | Romania | 125mg | sol inj. in stilou injector (pen) preumplut | Status unknown | Bristol-Myers Squibb Pharma Eeig |
| ORENCIA 125 mg/ml | Romania | 125mg/ml | sol inj. in seringa pre-umpluta | Status unknown | Bristol-Myers Squibb Pharma Eeig |
| ORENCIA 250 mg | Romania | 250mg | pulb. pt.conc. pt.sol. perf. | Status unknown | Bristol-Myers Squibb Pharma Eeig |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, MS and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
